GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » Change In Receivables

CStone Pharmaceuticals (HKSE:02616) Change In Receivables : HK$51.7 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Change In Receivables?

CStone Pharmaceuticals's change in receivables for the quarter that ended in Dec. 2024 was HK$58.9 Mil. It means CStone Pharmaceuticals's Accounts Receivable declined by HK$58.9 Mil from Jun. 2024 to Dec. 2024 .

CStone Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2024 was HK$51.8 Mil. It means CStone Pharmaceuticals's Accounts Receivable declined by HK$51.8 Mil from Dec. 2023 to Dec. 2024 .

CStone Pharmaceuticals's Accounts Receivable for the quarter that ended in Dec. 2024 was HK$89.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CStone Pharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2024 was 100.09.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CStone Pharmaceuticals's liquidation value for the six months ended in Dec. 2024 was HK$-160.9 Mil.


CStone Pharmaceuticals Change In Receivables Historical Data

The historical data trend for CStone Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Change In Receivables Chart

CStone Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only - -144.00 45.19 -104.24 51.79

CStone Pharmaceuticals Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.04 -118.93 14.69 -7.17 58.90

CStone Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$51.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CStone Pharmaceuticals  (HKSE:02616) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CStone Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=89.609/163.397*91
=100.09

2. In Ben Graham's calculation of liquidation value, CStone Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

CStone Pharmaceuticals's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=718.476-1099.27+0.75 * 89.609+0.5 * 305.457
=-160.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CStone Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


CStone Pharmaceuticals Business Description

Traded in Other Exchanges
Address
218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Suzhou, CHN, 215123
CStone Pharmaceuticals is engaged in the development and commercialization of tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.
Executives
Pfizer Inc. 2201 Interest of corporation controlled by you
Yang Jianxin 2101 Beneficial owner
Boyu Capital Fund Ii, L.p. 2201 Interest of corporation controlled by you
Boyu Capital General Partner Ii, L.p. 2201 Interest of corporation controlled by you
Boyu Capital General Partner Ii, Ltd. 2201 Interest of corporation controlled by you
Boyu Capital Holdings Ltd. 2201 Interest of corporation controlled by you
Graceful Beauty Limited 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Jian Kang Chuang Ye Tou Zi Guan Li Zhong Xin You Xian He Huo 2501 Other
Su Zhou Gong Ye Yuan Qu Yuan He Yuan Dian Chuang Ye Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Guan Wei Hui 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Jing Ji Fa Zhan You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Yuan He Kong Gu Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Ji Ming Gu Quan Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo 2101 Beneficial owner

CStone Pharmaceuticals Headlines

No Headlines